Metastatic Melanoma Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014561099
Market Monitor Global
Oct-2021
Life Sciences
103 Pages

This report contains market size and forecasts of Metastatic Melanoma Drug in global, including the following market information:
Global Metastatic Melanoma Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Metastatic Melanoma Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Metastatic Melanoma Drug companies in 2020 (%)
The global Metastatic Melanoma Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metastatic Melanoma Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Melanoma Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Metastatic Melanoma Drug Market Segment Percentages, By Type, 2020 (%)
AGI-134
ALT-801
ALT-803
AMG-232
Others

Global Metastatic Melanoma Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Metastatic Melanoma Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Metastatic Melanoma Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Metastatic Melanoma Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Melanoma Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Metastatic Melanoma Drug revenues share in global market, 2020 (%)
Key companies Metastatic Melanoma Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Metastatic Melanoma Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.
Morphotek, Inc.
NewLink Genetics Corporation
Novartis AG
Omeros Corporation
Oncolytics Biotech Inc.
OncoSec Medical Inc.
Ono Pharmaceutical Co., Ltd.
Pfizer Inc.
Pharmis Biofarmaceutica, Lda.
Philogen S.p.A.
Plexxikon Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Metastatic Melanoma Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Melanoma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Melanoma Drug Overall Market Size
2.1 Global Metastatic Melanoma Drug Market Size: 2021 VS 2027
2.2 Global Metastatic Melanoma Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Metastatic Melanoma Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Metastatic Melanoma Drug Players in Global Market
3.2 Top Global Metastatic Melanoma Drug Companies Ranked by Revenue
3.3 Global Metastatic Melanoma Drug Revenue by Companies
3.4 Global Metastatic Melanoma Drug Sales by Companies
3.5 Global Metastatic Melanoma Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Metastatic Melanoma Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Metastatic Melanoma Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metastatic Melanoma Drug Players in Global Market
3.8.1 List of Global Tier 1 Metastatic Melanoma Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Metastatic Melanoma Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Metastatic Melanoma Drug Market Size Markets, 2021 & 2027
4.1.2 AGI-134
4.1.3 ALT-801
4.1.4 ALT-803
4.1.5 AMG-232
4.1.6 Others
4.2 By Type - Global Metastatic Melanoma Drug Revenue & Forecasts
4.2.1 By Type - Global Metastatic Melanoma Drug Revenue, 2016-2021
4.2.2 By Type - Global Metastatic Melanoma Drug Revenue, 2022-2027
4.2.3 By Type - Global Metastatic Melanoma Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Metastatic Melanoma Drug Sales & Forecasts
4.3.1 By Type - Global Metastatic Melanoma Drug Sales, 2016-2021
4.3.2 By Type - Global Metastatic Melanoma Drug Sales, 2022-2027
4.3.3 By Type - Global Metastatic Melanoma Drug Sales Market Share, 2016-2027
4.4 By Type - Global Metastatic Melanoma Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Melanoma Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Metastatic Melanoma Drug Revenue & Forecasts
5.2.1 By Application - Global Metastatic Melanoma Drug Revenue, 2016-2021
5.2.2 By Application - Global Metastatic Melanoma Drug Revenue, 2022-2027
5.2.3 By Application - Global Metastatic Melanoma Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Metastatic Melanoma Drug Sales & Forecasts
5.3.1 By Application - Global Metastatic Melanoma Drug Sales, 2016-2021
5.3.2 By Application - Global Metastatic Melanoma Drug Sales, 2022-2027
5.3.3 By Application - Global Metastatic Melanoma Drug Sales Market Share, 2016-2027
5.4 By Application - Global Metastatic Melanoma Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Metastatic Melanoma Drug Market Size, 2021 & 2027
6.2 By Region - Global Metastatic Melanoma Drug Revenue & Forecasts
6.2.1 By Region - Global Metastatic Melanoma Drug Revenue, 2016-2021
6.2.2 By Region - Global Metastatic Melanoma Drug Revenue, 2022-2027
6.2.3 By Region - Global Metastatic Melanoma Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Metastatic Melanoma Drug Sales & Forecasts
6.3.1 By Region - Global Metastatic Melanoma Drug Sales, 2016-2021
6.3.2 By Region - Global Metastatic Melanoma Drug Sales, 2022-2027
6.3.3 By Region - Global Metastatic Melanoma Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Metastatic Melanoma Drug Revenue, 2016-2027
6.4.2 By Country - North America Metastatic Melanoma Drug Sales, 2016-2027
6.4.3 US Metastatic Melanoma Drug Market Size, 2016-2027
6.4.4 Canada Metastatic Melanoma Drug Market Size, 2016-2027
6.4.5 Mexico Metastatic Melanoma Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Metastatic Melanoma Drug Revenue, 2016-2027
6.5.2 By Country - Europe Metastatic Melanoma Drug Sales, 2016-2027
6.5.3 Germany Metastatic Melanoma Drug Market Size, 2016-2027
6.5.4 France Metastatic Melanoma Drug Market Size, 2016-2027
6.5.5 U.K. Metastatic Melanoma Drug Market Size, 2016-2027
6.5.6 Italy Metastatic Melanoma Drug Market Size, 2016-2027
6.5.7 Russia Metastatic Melanoma Drug Market Size, 2016-2027
6.5.8 Nordic Countries Metastatic Melanoma Drug Market Size, 2016-2027
6.5.9 Benelux Metastatic Melanoma Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Metastatic Melanoma Drug Revenue, 2016-2027
6.6.2 By Region - Asia Metastatic Melanoma Drug Sales, 2016-2027
6.6.3 China Metastatic Melanoma Drug Market Size, 2016-2027
6.6.4 Japan Metastatic Melanoma Drug Market Size, 2016-2027
6.6.5 South Korea Metastatic Melanoma Drug Market Size, 2016-2027
6.6.6 Southeast Asia Metastatic Melanoma Drug Market Size, 2016-2027
6.6.7 India Metastatic Melanoma Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Metastatic Melanoma Drug Revenue, 2016-2027
6.7.2 By Country - South America Metastatic Melanoma Drug Sales, 2016-2027
6.7.3 Brazil Metastatic Melanoma Drug Market Size, 2016-2027
6.7.4 Argentina Metastatic Melanoma Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Metastatic Melanoma Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Metastatic Melanoma Drug Sales, 2016-2027
6.8.3 Turkey Metastatic Melanoma Drug Market Size, 2016-2027
6.8.4 Israel Metastatic Melanoma Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Metastatic Melanoma Drug Market Size, 2016-2027
6.8.6 UAE Metastatic Melanoma Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporate Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Major Product Offerings
7.1.4 Merck & Co., Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.1.5 Merck & Co., Inc. Key News
7.2 Merck KGaA
7.2.1 Merck KGaA Corporate Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Metastatic Melanoma Drug Major Product Offerings
7.2.4 Merck KGaA Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.2.5 Merck KGaA Key News
7.3 Millennium Pharmaceuticals, Inc.
7.3.1 Millennium Pharmaceuticals, Inc. Corporate Summary
7.3.2 Millennium Pharmaceuticals, Inc. Business Overview
7.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Major Product Offerings
7.3.4 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.3.5 Millennium Pharmaceuticals, Inc. Key News
7.4 Morphotek, Inc.
7.4.1 Morphotek, Inc. Corporate Summary
7.4.2 Morphotek, Inc. Business Overview
7.4.3 Morphotek, Inc. Metastatic Melanoma Drug Major Product Offerings
7.4.4 Morphotek, Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.4.5 Morphotek, Inc. Key News
7.5 NewLink Genetics Corporation
7.5.1 NewLink Genetics Corporation Corporate Summary
7.5.2 NewLink Genetics Corporation Business Overview
7.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Major Product Offerings
7.5.4 NewLink Genetics Corporation Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.5.5 NewLink Genetics Corporation Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Metastatic Melanoma Drug Major Product Offerings
7.6.4 Novartis AG Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.6.5 Novartis AG Key News
7.7 Omeros Corporation
7.7.1 Omeros Corporation Corporate Summary
7.7.2 Omeros Corporation Business Overview
7.7.3 Omeros Corporation Metastatic Melanoma Drug Major Product Offerings
7.4.4 Omeros Corporation Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.7.5 Omeros Corporation Key News
7.8 Oncolytics Biotech Inc.
7.8.1 Oncolytics Biotech Inc. Corporate Summary
7.8.2 Oncolytics Biotech Inc. Business Overview
7.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Major Product Offerings
7.8.4 Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.8.5 Oncolytics Biotech Inc. Key News
7.9 OncoSec Medical Inc.
7.9.1 OncoSec Medical Inc. Corporate Summary
7.9.2 OncoSec Medical Inc. Business Overview
7.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Major Product Offerings
7.9.4 OncoSec Medical Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.9.5 OncoSec Medical Inc. Key News
7.10 Ono Pharmaceutical Co., Ltd.
7.10.1 Ono Pharmaceutical Co., Ltd. Corporate Summary
7.10.2 Ono Pharmaceutical Co., Ltd. Business Overview
7.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Major Product Offerings
7.10.4 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.10.5 Ono Pharmaceutical Co., Ltd. Key News
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Corporate Summary
7.11.2 Pfizer Inc. Metastatic Melanoma Drug Business Overview
7.11.3 Pfizer Inc. Metastatic Melanoma Drug Major Product Offerings
7.11.4 Pfizer Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.11.5 Pfizer Inc. Key News
7.12 Pharmis Biofarmaceutica, Lda.
7.12.1 Pharmis Biofarmaceutica, Lda. Corporate Summary
7.12.2 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Business Overview
7.12.3 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Major Product Offerings
7.12.4 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.12.5 Pharmis Biofarmaceutica, Lda. Key News
7.13 Philogen S.p.A.
7.13.1 Philogen S.p.A. Corporate Summary
7.13.2 Philogen S.p.A. Metastatic Melanoma Drug Business Overview
7.13.3 Philogen S.p.A. Metastatic Melanoma Drug Major Product Offerings
7.13.4 Philogen S.p.A. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.13.5 Philogen S.p.A. Key News
7.14 Plexxikon Inc.
7.14.1 Plexxikon Inc. Corporate Summary
7.14.2 Plexxikon Inc. Business Overview
7.14.3 Plexxikon Inc. Metastatic Melanoma Drug Major Product Offerings
7.14.4 Plexxikon Inc. Metastatic Melanoma Drug Sales and Revenue in Global (2016-2021)
7.14.5 Plexxikon Inc. Key News
8 Global Metastatic Melanoma Drug Production Capacity, Analysis
8.1 Global Metastatic Melanoma Drug Production Capacity, 2016-2027
8.2 Metastatic Melanoma Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Metastatic Melanoma Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Metastatic Melanoma Drug Supply Chain Analysis
10.1 Metastatic Melanoma Drug Industry Value Chain
10.2 Metastatic Melanoma Drug Upstream Market
10.3 Metastatic Melanoma Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Metastatic Melanoma Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Metastatic Melanoma Drug in Global Market
Table 2. Top Metastatic Melanoma Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Metastatic Melanoma Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Metastatic Melanoma Drug Revenue Share by Companies, 2016-2021
Table 5. Global Metastatic Melanoma Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Metastatic Melanoma Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Metastatic Melanoma Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Metastatic Melanoma Drug Product Type
Table 9. List of Global Tier 1 Metastatic Melanoma Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Melanoma Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Merck & Co., Inc.
Merck KGaA
Millennium Pharmaceuticals, Inc.
Morphotek, Inc.
NewLink Genetics Corporation
Novartis AG
Omeros Corporation
Oncolytics Biotech Inc.
OncoSec Medical Inc.
Ono Pharmaceutical Co., Ltd.
Pfizer Inc.
Pharmis Biofarmaceutica, Lda.
Philogen S.p.A.
Plexxikon Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE